Oral melatonin as a new tool for neuroprotection in preterm newborns: study protocol for a randomized controlled trial.

Background: Prevention of neurodevelopmental impairment due to preterm birth is a major health challenge. Despite advanced obstetric and neonatal care, to date there are few neuroprotective molecules available. Melatonin has been shown to have anti-oxidant/anti-inflammatory effects and to reduce bra...

Descripción completa

Detalles Bibliográficos

Publicado en:	Trials Vol. 22; no. 1; pp. 1 - 13
Autores principales:	Garofoli, Francesca, Longo, Stefania, Pisoni, Camilla, Accorsi, Patrizia, Angelini, Micol, Aversa, Salvatore, Caporali, Camilla, Cociglio, Sara, De Silvestri, Annalisa, Fazzi, Elisa, Rizzo, Vittoria, Tzialla, Chryssoula, Zecca, Marco, Orcesi, Simona
Formato:	Journal Article
Publicado:	BioMed Central 1/22/2021
Acceso en línea:	Ver este registro en EBSCOhost